The Institute for Continuing Healthcare Education

The ABC’s of GLP’s and Psoriatic Disease Instagram Live

DO, MS, FAAD

Discuss the mechanistic rationale of combining interleukin (IL)-17 biologics and glucagon-like peptide (GLP)-1 receptor agonists in psoriatic disease management for patients with obesity, including disease control and weight loss.

Identify strategies for integrating GLP-1 receptor agonists into dermatology practice, considering patient support programs to improve access and adherence

large_psoriasis elbow stock image.jpg

medium_psoriasis elbow stock image.jpg

small_psoriasis elbow stock image.jpg

thumbnail_psoriasis elbow stock image.jpg

psoriasis elbow stock image.jpg

Psoriasis

Live Evaluations

The ABC’s of GLP’s and Psoriatic Disease

The ABC’s of GLP’s and Psoriatic Disease

About

Learning Objectives

Intended Audience

Faculty

Accreditation Statement

Credit Designation Statement

Disclosures